As of Apr 18
| +0.06 / +1.54%|
The 3 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a +254.43% increase from the last price of 3.95.
The current consensus among 3 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.